| Patents for A61P 17 - Drugs for dermatological disorders (106,455) |
|---|
| 06/29/2005 | CN1208073C Ointment for treating various skin diseases and preparation method thereof |
| 06/29/2005 | CN1208069C Process for preparing liquid medicine to treat dermatopathy |
| 06/29/2005 | CN1208052C Coenzyme Q10 precursor liposome and preparation method |
| 06/28/2005 | US6911456 Related to organ systems which respond to estrogen agonists or antagonists; in particular, 2-phenyl-3-aroylbenzothiophenes and 1-(alkylaminoethoxy phenyl)-1-phenyl-2-phenylbut-1-enes have wide application as estrogen agonists |
| 06/28/2005 | US6911444 Non-steroidal IL-5 inhibitors, processes and intermediates for their preparation and pharmaceutical compositions comprising said inhibitors |
| 06/28/2005 | US6911443 Imidazopyrimidine derivatives and triazolopyrimidine derivatives |
| 06/28/2005 | US6911440 For the treatment of inflammatory rheumatic/rheumatoid diseases and/or pain, rheumatoid arthritis |
| 06/28/2005 | US6911439 Alpha 4 beta 1 integrin and CD49d/ CD29 (vla-4); antiinflammatory agents |
| 06/28/2005 | US6911426 Inhibitor of apoptosis proteins (IAP); survivin |
| 06/28/2005 | US6911211 Pharmaceutical and cosmetic carrier or composition for topical application |
| 06/28/2005 | CA2317411C Controlled release delivery of peptide or protein |
| 06/28/2005 | CA2146775C Novel vitamin d analogues |
| 06/28/2005 | CA2138110C Cosmetic and/or dermatologic composition containing salicylic acid derivatives and process for their solubilization |
| 06/23/2005 | WO2005056030A1 Penetration enhancing agent and method of its production from the hemp seeds |
| 06/23/2005 | US20050137263 e.g., 2-[(4-Ethyl-2-fluorophenyl)amino]-3,4-difluoro-N-(2-hydroxyethoxy)benzamide, is administered to treat arthritis |
| 06/23/2005 | US20050137249 Cyclization at the 5,6-position of the benzo[e]naphtho[3,2-h]azulene, oxepane or thiepane with a mercaptoacetic acid ester followed by etherification, amination or sulfiding at the 2-position; antiarthritic and antiinflammatory agents, analgesics; biosynthesis inhibitors of interleukin-1; nontoxic |
| 06/23/2005 | US20050137242 Betamimetics having a long-lasting activity, processes for preparing them, and their use as medicaments |
| 06/23/2005 | US20050137239 Thiazole derivatives |
| 06/23/2005 | US20050137221 Keratinocyte-proliferative diseases; inhibitor of solubilization of Epidermal Growth Factor; 3,4,5-trihydroxy-1-(4'-methoxybenzenesulfonyl)-piperidine-2-carboxylic acid hydroxamide; 7-acetoxy-5-(4'-methoxybenzenesulfonyl)-2,2-dimethyl-h exahydro-[1,3]dioxolo[4,5-c]pyridine-6-carboxy ester intermediate |
| 06/23/2005 | US20050137214 Inhibitors of cyclin-dependent kinases 4 (cdk4); treating proliferative disorders such as cancer; salt of 6-Acetyl-8-cyclopentyl-5-methyl-2-(5-piperazin-1-yl-pyridin-2-ylamino)-8H-pyrido[2,3-d]pyrimidin-7-one for example |
| 06/23/2005 | US20050137212 Hppars activators |
| 06/23/2005 | US20050137180 Porphrins or azaporprins for photosensitizing therapy or photodetection with azaporprins for cardiovascular disorders and coordination with metals |
| 06/23/2005 | US20050137176 Receptor ligands for cosmetics or skins for maintaining cutaneous homeostasis |
| 06/23/2005 | US20050137175 Composition with ecdysteroid with water or milk for lotions for skin and applying to prevent hair loss |
| 06/23/2005 | US20050137167 Inhibiting FGF growth factor with heparins; antitumor agents; angiogenesis inhibitor; antidiabetic agent treating diabetic retinopathy; antiinflammatory agent; treating retrolenticular fibroplasia, psoriasis, restenosis after angioplasty and after coronary by-pass; chemical intermediates; drug delivery |
| 06/23/2005 | US20050136133 Administering an anti-allergy composition of a wood-vinegar distilled solution, colorless and transparent |
| 06/23/2005 | US20050136129 Administering to postsurgery and/or immobile persons; comprised of proteins, carbohydrates, fats with equivalents of arginine, ascorbic acid and alpha tocopherol |
| 06/23/2005 | CA2548901A1 Use of goat blood serum derived antibodies obtained after challenge with hiv lysate for veterinary treatment |
| 06/23/2005 | CA2545112A1 Novel ligands that are activators of the rar receptors, use in human medicine and in cosmetics |
| 06/23/2005 | CA2539003A1 Compositions and methods for topical treatment of skin infection |
| 06/22/2005 | EP1544299A1 Modified chimeric polypeptides with improved pharmacokinetic properties |
| 06/22/2005 | EP1544194A1 4-(substituted aryl)-5-hydroxyisoquinolinone derivative |
| 06/22/2005 | EP1543830A1 Antiseptic bactericides and cosmetics, drugs and foods containing the antiseptic bactericides |
| 06/22/2005 | EP1543829A1 Antiseptic bactericides and cosmetics, drugs and foods containing the antiseptic bactericides |
| 06/22/2005 | EP1543824A2 Thiazole derivatives to counter advanced glycation |
| 06/22/2005 | EP1543821A1 External preparation |
| 06/22/2005 | EP1543034A2 Treatment and prophylaxis with 4-1bb-binding agents |
| 06/22/2005 | EP1543024A2 Cyclic amp phosphodiesterase 4d7 isoforms and methods of use |
| 06/22/2005 | EP1543003A2 Imidazo[1,2-a]pyridines |
| 06/22/2005 | EP1543001A1 Novel pyrazolopyridine derivatives as pharmaceutical agents |
| 06/22/2005 | EP1542980A1 5-aryltetrazole compounds, compositions thereof, and uses therefor |
| 06/22/2005 | EP1542978A1 Novel bio-active molecules |
| 06/22/2005 | EP1542977A1 2,5-dioxoimidazolidin-4-yl acetamides and analogues as inhibitors of metalloproteinase mmp12. |
| 06/22/2005 | EP1542974A1 Novel compound |
| 06/22/2005 | EP1542972A2 Cyclooxygenase- 2 selective inhibitors, compositions and methods of use |
| 06/22/2005 | EP1542724A2 Antibodies directed to monocyte chemo-attractant protein-1 (mcp-1) and uses thereof |
| 06/22/2005 | EP1542692A1 Amino-pyridine, -pyridine and pyridazine derivatives for use as vanilloid receptor ligands for the treatment of pain |
| 06/22/2005 | EP1542671A1 Composition based on triethyl citrate for the treatment of bacterial infections of the skin |
| 06/22/2005 | EP1542653A1 A topical composition for treatment of skin disorders |
| 06/22/2005 | EP1469856A4 8-heteroaryl xanthine adenosine a sb 2b /sb receptor antagonists |
| 06/22/2005 | EP1381611B1 Metal substituted non centrosimmetrical phthalocyanine analogues, their preparation and use in photodynamic therapy and in vivo diagnostic |
| 06/22/2005 | EP1372656B1 Pyrazolo[4,3-d]pyrimidinone compounds as cgmp pde inhibitors |
| 06/22/2005 | EP1345933B1 Process for making substituted 8-arylquinolinium benzenesulfonate |
| 06/22/2005 | EP1272200B1 Divided dose therapies with vascular damaging activity |
| 06/22/2005 | EP1267915B1 Activated protein c for treating pancreatitis |
| 06/22/2005 | EP1173201B1 Method for the treatment of fibrosis using an antagonist of the integrin alpha-4 subunit |
| 06/22/2005 | EP1171136B1 Immunomodulating compositions comprising urea derivatives for use in the treatment of inflammatory diseases |
| 06/22/2005 | EP1154774B1 Quinazoline derivatives as angiogenesis inhibitors |
| 06/22/2005 | EP1131039B1 Use of a substance binding with the peripheral benzodiazepin receptor for treating skin stress |
| 06/22/2005 | EP1040111B1 Integrin receptor antagonists |
| 06/22/2005 | EP1007533B1 Bioconjugates and delivery of bioactive agents |
| 06/22/2005 | EP0927254B1 Antagonists of interleukin-15 |
| 06/22/2005 | EP0892644B1 In vivo gene transfer methods for wound healing |
| 06/22/2005 | CN1630730A Methods for detecting and treating the early onset of aging-related conditions |
| 06/22/2005 | CN1630709A Human glucagon-like-peptide-1 mimics and their use in the treatment of diabetes and related conditions |
| 06/22/2005 | CN1630664A Caspase-8 binding protein, its preparation and use |
| 06/22/2005 | CN1630657A Deazapurines and uses thereof |
| 06/22/2005 | CN1630637A Novel arylheteroalkylamine derivatives |
| 06/22/2005 | CN1630635A Amino alcohol derivatives or phosphonic acid derivatives and pharmaceutical compositions containing these |
| 06/22/2005 | CN1630633A N-biphenylmethyl aminocycloalkanecarboxamide derivatives with a substiituent on the methyl useful as bradykinin antagonists |
| 06/22/2005 | CN1630535A Inhibition of STAT-1 |
| 06/22/2005 | CN1630526A Systems and methods for treating patients with processed lipoaspirate cells |
| 06/22/2005 | CN1630521A Oral compositions and methods for prevention, reduction and treatment of radiation injury |
| 06/22/2005 | CN1630516A Combinations of antibodies selective for a tumor necrosis factor-related apoptosis-inducing ligand receptor and other therapeutic agents |
| 06/22/2005 | CN1630515A Compounds active at the glucocorticoid receptor II |
| 06/22/2005 | CN1628848A Multifunctional skin lotion for painless injection and trauma clearance |
| 06/22/2005 | CN1628836A Chinese patent drug for treating leucoderma |
| 06/22/2005 | CN1628822A Chinese medicinal liquor for treating psoriasis and preparation method thereof |
| 06/22/2005 | CN1628821A Medicinal frost formulation for treating psoriasis and its preparing process |
| 06/22/2005 | CN1628809A Chinese traditional medicine for treating pruritus |
| 06/22/2005 | CN1628807A Freckle removing medicine |
| 06/22/2005 | CN1628805A Chloasma treating medicine |
| 06/22/2005 | CN1628803A Freckle removing medicine |
| 06/22/2005 | CN1628800A Chinese medicinal preparation for treating alopecia |
| 06/22/2005 | CN1628789A Tincture containing cantharides and drynaria and compound capsule for treating hair shedding |
| 06/22/2005 | CN1628776A Medicine for treating chronic hives |
| 06/22/2005 | CN1628764A Creat formulation and its preparation process |
| 06/22/2005 | CN1628756A Externally applied medicine for treating mycosis |
| 06/22/2005 | CN1628754A Local externally applied itch stopping garlic paint |
| 06/22/2005 | CN1628737A Pure natural capsule for whitening skin |
| 06/22/2005 | CN1628717A Method for preparing psoriasis treating capsule |
| 06/22/2005 | CN1628675A Vulnerary, its preparation method and process of using |
| 06/22/2005 | CN1628631A Pox removing cream |
| 06/22/2005 | CN1207298C Triazolopurine derivatives, drug compositions containing the same and adenosine A3 receptor affinitive agents |
| 06/22/2005 | CN1207049C Lotion for treating beriberi and tinea pedis |
| 06/22/2005 | CN1207040C Externally applied pharmaceutical composition for treating skin disease and venereal disease |
| 06/22/2005 | CN1207038C Chinese medicinal composition for removing speckles and its preparing method |
| 06/22/2005 | CN1207017C Prepn of leukoderma-treating medicine |
| 06/22/2005 | CN1207016C Burn and scald treating oil |
| 06/22/2005 | CN1207013C Pox removing liquid |